RUNX2 and breast cancer: Recent whole-genome and whole-exome sequencing studies have revealed that RUNX1 mutations are common in BC [21, 22], and in particular, some point mutations in RUNX1 DNA-binding domain abolish its DNA binding activity [21, 22], while RUNX2 mutations are rare [23].